Moreover, the role of medical treatments, including glucocorticoids, immunomodulators, and tumor necrosis factor-α inhibitors, in the pathogenesis of NAFLD in IBD also remains unclear [17]. This evidence concerns the gene TNF and inflammatory bowel disease.